Reply to Borrelli et al.: Novel Drug Targets for Central Apneas in Heart Failure: On the Road
- PMID: 34086535
- PMCID: PMC8480252
- DOI: 10.1164/rccm.202104-1076LE
Reply to Borrelli et al.: Novel Drug Targets for Central Apneas in Heart Failure: On the Road
Comment on
-
Research Priorities for Patients with Heart Failure and Central Sleep Apnea. An Official American Thoracic Society Research Statement.Am J Respir Crit Care Med. 2021 Mar 15;203(6):e11-e24. doi: 10.1164/rccm.202101-0190ST. Am J Respir Crit Care Med. 2021. PMID: 33719931 Free PMC article.
-
Novel Drug Targets for Central Apneas in Heart Failure: On the Road.Am J Respir Crit Care Med. 2021 Aug 15;204(4):490-491. doi: 10.1164/rccm.202104-0846LE. Am J Respir Crit Care Med. 2021. PMID: 34086532 Free PMC article. No abstract available.
References
-
- Giannoni A, Borrelli C, Mirizzi G, Richerson GB, Emdin M, Passino C. Benefit of buspirone on chemoreflex and central apnoeas in heart failure: a randomized controlled crossover trial. Eur J Heart Fail . 2021;23:312–320. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical